This study explored the safety and efficacy of a CXCR2 agonist and plerixafor for mobilization of HSCs for hematopoietic stem cell transplantation in patients with MM.
Last week, the biotech sector was in focus, with regular pipeline and regulatory updates. While nothing much came from biotech majors, Amicus FOLD and Editas EDIT were in focus on updates. Recap of ...